The biotech and anti-aging sectors represent a massive blind spot in Web3 discourse. With an estimated $200B addressable market, these niches generate enormous value yet remain largely absent from mainstream crypto conversations.

Beyond the hype cycles of Layer 2s and token launches, there's a compelling question worth exploring: will decentralized science (DeSci) protocols become the infrastructure layer for biotech innovation? The intersection of blockchain transparency and life sciences research could unlock new funding models, accelerate peer review processes, and democratize access to breakthrough discoveries.

Imagine scientific advancement moving at the speed of Web3 development. The structural advantages are there—immutable research records, tokenized incentives, global collaboration without borders. Whether DeSci fulfills this promise depends on solving real execution challenges, but the foundation is worth watching.